PharmaEngine Inc 2024 SR
The report highlights PharmaEngine's 14th year of sustainability reporting, focusing on its Virtual Pharmaceutical Company model for oncology drug development. In 2024, the company completed its initial Scope 3 GHG inventory and set a target to source 70% of its electricity from green energy by 2030. It also achieved the top 5% in the Corporate Governance Evaluation for TPEX companies. Social initiatives included health education seminars for pancreatic cancer patients and support for disadvantaged children in Hualien following the 2024 earthquake.
Company: PharmaEngine Inc
Sector: Health Care
Country: Taiwan
Year: 2024
Type: SR
Pages: 79
PharmaEngine Inc
Sustainability Report
The report highlights PharmaEngine's 14th year of sustainability reporting, focusing on its Virtual Pharmaceutical Company model for oncology drug development. In 2024, the company completed its initial Scope 3 GHG inventory and set a target to source 70% of its electricity from green energy by 2030. It also achieved the top 5% in the Corporate Governance Evaluation for TPEX companies. Social initiatives included health education seminars for pancreatic cancer patients and support for disadvantaged children in Hualien following the 2024 earthquake.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Published
Jun 23, 2025
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Sustainable Development Goals
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Water Consumption
Total Waste
Women on Board
Women in Management
Net Zero Target
Employees